Crinetics Pharmaceuticals (CRNX) Times Interest Earned (2017)

Crinetics Pharmaceuticals' Times Interest Earned history runs 10 years deep, the most recent figure standing at -$1.15 for Q1 2026.

• In Q1 2026, Times Interest Earned rose 97.93% year-over-year to -$1.15; the TTM figure through Mar 2026 stood at -$4.49 (up 98.25% YoY), while the FY2025 annual figure was -$1.32, down 31.35% from the prior year.
• Times Interest Earned for Q1 2026 stood at -$1.15, up from -$80.42 in the prior quarter.
• The five-year high for Times Interest Earned was $61.09 in Q4 2024, with the low at -$158.52 in Q4 2022.
• The 5-year median for Times Interest Earned is -$1.57 (2022), against an average of -$19.74.
• The sharpest annual moves came in 2024 and 2025: Times Interest Earned jumped 169.8% in 2024, then sank 25788.49% in 2025.
• Crinetics Pharmaceuticals' Times Interest Earned stood at -$158.52 in 2022, then surged by 44.79% to -$87.51 in 2023, then surged by 169.8% to $61.09 in 2024, then slumped by 231.66% to -$80.42 in 2025, then jumped by 98.56% to -$1.15 in 2026.
• Business Quant data shows CRNX's Times Interest Earned at -$1.15 in Q1 2026, -$80.42 in Q4 2025, and -$0.71 in Q3 2025.